(Q36912033)

17 August 2017

0 references

1 reference

title

Efficacy and safety of statin monotherapy in older adults: a meta-analysis (English)

1 reference

17 August 2017

1 reference

Caroline G P Roberts

1

1 reference

17 August 2017

Eliseo Guallar

series ordinal

2

1 reference

17 August 2017

Annabelle Rodriguez

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

The Journals of Gerontology

17 August 2017

published in

1 reference

17 August 2017

volume

62

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

879-887

1 reference

Lifetime risk of coronary heart disease by cholesterol levels at selected ages

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Implications of statin adverse effects in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Statin use after acute myocardial infarction: a nationwide study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Familial cancer prevalence spanning eight years. Family N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Ischemic heart disease risk factors after age 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Statins and cancer: a case of meta-uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F62.8.879

21 January 2018

Identifiers

DOI

10.1093/GERONA/62.8.879

1 reference

17 August 2017

1 reference